To further analyze the mechanisms underlying the dysregulation of miR-23a in pancreatic cancer development, we quantitated miR-23a expression in normal pancreatic epithelial, ADM, and pancreatic intraepithelial neoplasia in mouse models. The gene discussed is ADM; the disease is pancreatic neoplasm.